Prognostic factors of 90-day mortality in patients hospitalised with COVID-19

Christian Brieghel1, Peter Ellekvist, Marie Louise Lund

  • 1christian.brieghel@regionh.dk.

Insights

Prognostic factors for COVID-19 mortality include age, comorbidities, abnormal blood tests, and oxygen needs. These factors independently increase 90-day mortality risk in hospitalized patients.

Area of Science:

  • Internal Medicine
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • COVID-19 disproportionately affects elderly patients with comorbidities.
  • Accurate prognostication for COVID-19 remains a significant clinical challenge.

Purpose of the Study:

  • To assess 90-day mortality in hospitalized COVID-19 patients.
  • To identify predictors of mortality including comorbidities, biochemical markers, and oxygen requirements.

Main Methods:

  • Analysis of a consecutive single-center cohort of 263 hospitalized patients with confirmed COVID-19.
  • Stratification of 90-day mortality based on comorbidities, biochemical markers, and oxygen support.
  • Multivariable analysis to determine independent predictors of mortality.

Main Results:

  • Overall 90-day mortality was 29%; ICU mortality was 35%.
  • Independent predictors of increased 90-day mortality included advancing age, higher Charlson Comorbidity Index (CCI) score, increased number of abnormal blood tests, and greater supplemental oxygen requirement.
  • Alcohol abuse, liver disease, and elevated urea were associated with mortality in univariable analysis.

Conclusions:

  • Hospitalized COVID-19 patients face a significant 90-day mortality risk.
  • Age, comorbidities, laboratory abnormalities, and oxygen support are independent prognostic indicators for mortality.
  • ICU mortality was lower than anticipated, suggesting effective critical care management.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
577
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
717
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
554
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
503
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
289